Is Broadcom Stock Now a Better Buy Than Nvidia?

Nvidia is presented as the better AI chip investment versus Broadcom, with faster overall revenue growth of 85% year over year in its fiscal Q1 2027 compared with Broadcom's 48% total revenue growth. Broadcom's AI semiconductor revenue is growing faster at 143% and management expects about 200% growth next quarter, but the article argues Nvidia is still cheaper on forward P/E despite Broadcom's recent selloff. The piece is opinionated rather than event-driven, so market impact is limited.

Analysis

The market is implicitly treating this as a two-layer competition: platform GPU share versus custom silicon share. That matters because the second-order winner is not necessarily the highest-growth chip vendor, but the ecosystem holder that can keep workloads sticky while pushing mix toward higher-margin attach rates in networking, software, and interconnect. NVDA still looks like the cleaner compounder because it monetizes the entire stack, while AVGO’s opportunity is more binary: each new hyperscaler design win can be large, but the ramp profile is lumpier and more customer-concentrated.

The key contrarian point is that AVGO’s recent reset may not be enough if investors are still underwriting near-perfect execution on a much longer-dated TAM. Custom AI silicon has better unit economics only when utilization is highly predictable; that means the upside is strongest in a narrow set of hyperscaler inference/training workloads, not across the broader market. If capex budgets tighten, custom chip programs are the first to be re-scoped because they require multi-year commitment and upfront engineering, whereas the GPU platform remains the default procurement choice.

For NVDA, the biggest risk is not demand slowing tomorrow, but margin normalization later as customers increasingly demand architectural concessions to reduce total cost per token. Still, the stock deserves a premium because it benefits from ecosystem inertia: software tooling, developer lock-in, and faster refresh cycles all support repeat purchases. The setup favors NVDA as the higher-quality duration asset, while AVGO is more of a selective trade on hyperscaler execution rather than a broad-based AI winner.

The market may be underestimating how much of AVGO’s AI narrative is already a call option on a handful of large customers. That concentration creates upside if those customers stay aggressive, but it also means any slip in one program can mechanically reset the multiple. In contrast, NVDA’s broader customer base and platform dominance make earnings more resilient even if AI spending becomes more discriminating over the next 2-3 quarters.

Key Decisions for Investors

• Stay long NVDA into the next 1-3 months as the cleaner quality-growth exposure; use pullbacks to add, with the thesis that platform lock-in supports a higher multiple even if growth decelerates modestly.
• Fade AVGO strength with a tactical underweight or short against NVDA over the next 4-8 weeks; the risk/reward favors NVDA if investors reprice concentration risk and execution uncertainty in custom silicon.
• If expressing the view via options, consider NVDA call spreads 2-4 months out to capture continued AI leadership with defined premium risk; target a 2:1 payoff if the market re-rates the name on durability.
• For AVGO bulls, wait for proof of conversion in hyperscaler deployment rather than chasing the current narrative; enter only on confirmation of another step-up in AI revenue guidance, since the downside is sharp if one major program slips.
• Avoid pairing long AVGO versus short legacy semiconductor names as a pure AI expression; the cleaner pair is long NVDA / short AVGO because it isolates platform versus custom-silicon execution risk.